Genetic Insights into the Gut-Lung Axis: Mendelian Randomization Analysis on Gut Microbiota, Lung Function, and COPD
Zi-Xuan Cheng,Jian-Lan Hua,Zhi-Jun Jie,Xing-Jing Li,Jing Zhang
DOI: https://doi.org/10.2147/copd.s441242
2024-03-05
International Journal of COPD
Abstract:Zi-Xuan Cheng, 1 Jian-Lan Hua, 1 Zhi-Jun Jie, 2 Xing-Jing Li, 3 Jing Zhang 1 1 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, the Fifth People's Hospital of Shanghai, Fudan University, Shanghai, People's Republic of China; 3 Department of Respiratory Medicine, Zhongshan Hospital Wusong Branch, Fudan University, Shanghai, People's Republic of China Correspondence: Jing Zhang, Email Background: Chronic obstructive pulmonary disease (COPD) is a respiratory disorder with a complex etiology involving genetic and environmental factors. The dysbiosis of gut microbiota has been implicated in COPD. Mendelian Randomization (MR) provides a tool to investigate causal links using genetic variants as instrumental variables. This study aims to employ MR analysis to explore the causal relationship between gut microbiota, lung function, and COPD. Methods: We utilized genome-wide association study (GWAS) data from MiBioGen, UK Biobank and FinnGen, which were related to gut microbial taxa, lung function parameters including forced vital capacity in one second (FEV 1 ), forced vital capacity (FVC), and percentage of predicted FEV 1 (FEV 1 %pred), as well as GWAS data for COPD. MR analysis was conducted to assess the causal effects of gut microbiota on lung function and the risk of COPD. Sensitivity analysis was utilized to examine the stability of the causal relationships. Multiple testing and reverse analysis were employed to evaluate the robustness of these relationships. Results: Using the IVW method, 64 causal correlations were identified. Through conducting sensitivity analysis, multiple testing, and reverse analysis, we identified 14 robust and stable causal relationships. The bacterial taxa that showed a positive association with lung function included Desulfovibrionaceae , Erysipelotrichales, Desulfovibrionales, Clostridiales, Clostridia, Deltaproteobacteria and Erysipelotrichia , while Selenomonadales and Negativicutes showed a negative association with lung function. The abundance of Holdemanella were positively correlated with the risk of COPD, while FamilyXIII exhibited a negative correlation with the risk of COPD. Conclusion: Several microbial taxa were discovered to have a positive causal correlation with lung function, offering potential insights into the development of probiotics. The presence of microbial taxa negatively correlated with lung function and positively correlated with COPD emphasized the potential impact of gut microbiota dysbiosis on respiratory health. Keywords: COPD, lung function, gut-lung axis, gut microbiota, Mendelian randomization analysis Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disorder characterized by progressive airflow limitation and persistent respiratory symptoms. It presents a substantial global health burden and is a leading cause of morbidity and mortality. 1 The development of COPD involves a complex interplay between genetic factors, such as predisposition, and environmental factors, including smoking, air pollution, and respiratory infections. Despite the diverse causes of COPD, current diagnostic and therapeutic approaches are limited, highlighting the need for a deeper understanding of its underlying mechanisms. 2 In recent years, there has been growing interest in the role of the gut microbiota, which has been found to influence various aspects of human health, including immune regulation and systemic inflammation. 3 Accumulating evidence suggests a potential link between the dysbiosis of the gut microbiota and the development of COPD. 4,5 Observational studies have identified gut microbiome dysbiosis in COPD patients, and rodent models have demonstrated its contribution to COPD development. 6,7 Furthermore, there have been reports on the associations between gut microbial dysbiosis and a decline in lung function in individuals with COPD. 8–10 However, establishing a causal relationship between the gut microbiota and COPD remains challenging. The dynamic nature of the gut microbiome introduces challenges when attempting to characterize it through a single cross-sectional study design. 11 This is due to the potential variability in microbial sequencing results, which can be influenced by various confounders and covariates. It is crucial to acknowledge that factors such as the use of inhalers, particularly inhaled corticosteroids (ICS), and antibiotics can act as confoundi -Abstract Truncated-
respiratory system